Orbis emerged from stealth in February 2024 with $28.1 million in seed funding. The Danish biotech, which aims to flip ...

Whether to fully subsidise the new generation weight loss drugs such as Mounjaro and Ozempic for obese Australians without ...

Eli Lilly is seeking to end a lawsuit filed by a pharmacy trade group against the Food and Drug Administration (FDA) by ...

Eli Lilly has asked to join in opposing a lawsuit brought by compounding pharmacies against the U.S. Food and Drug ...

Eli Lilly's Zepbound is challenging Wegovy in the obesity market, while U.S. health care costs are set to rise 9% in 2025, driven by specialty drugs and inflation.

Auvinen et al. examine genome-wide DNA methylation, imprinting, and gene expression in human placentas. Placentas from assisted reproductive technologies experience a variety of altered signaling ...

Here are some clinical trials that could send Big Pharma shares soaring, or crashing, in 2025. Eli Lilly. The world’s biggest ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

By itself, it’s not enough, but body mass index has years of evidence behind it and still has a place in clinical assessments ...

Eli Lilly (LLY) closed at $773.84 in the latest trading session, marking a -1.19% move from the prior day. The stock's change was less than the S&P 500's daily loss of 1.07%. At the same time, the Dow ...

Dr. Lilly, age 79, of Dublin, VA, passed away Christmas day in Roanoke, VA. Born April 21, 1945, in Radford, VA, he was the son of ...

It’s been another busy year in Indiana health care and life sciences, with headlines nearly every week announcing another ...